These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK. J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245 [Abstract] [Full Text] [Related]
3. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study. Carpenter TO, Keller M, Schwartz D, Mitnick M, Smith C, Ellison A, Carey D, Comite F, Horst R, Travers R, Glorieux FH, Gundberg CM, Poole AR, Insogna KL. J Clin Endocrinol Metab; 1996 Jun; 81(6):2381-8. PubMed ID: 8964881 [Abstract] [Full Text] [Related]
4. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. Drezner MK, Lyles KW, Haussler MR, Harrelson JM. J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520 [Abstract] [Full Text] [Related]
11. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity. Lyles KW, Drezner MK. J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432 [Abstract] [Full Text] [Related]
12. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia. Lyles KW, Harrelson JM, Drezner MK. J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353 [No Abstract] [Full Text] [Related]
13. Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male mice. Halstead LR, Weinstein RS, Cheng SL, Rifas L, Avioli LV. Am J Physiol; 1996 Jan; 270(1 Pt 1):E141-7. PubMed ID: 8772486 [Abstract] [Full Text] [Related]
16. Effects of therapy in X-linked hypophosphatemic rickets. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M. N Engl J Med; 1991 Dec 26; 325(26):1843-8. PubMed ID: 1660098 [Abstract] [Full Text] [Related]
17. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets. Lyles KW, Burkes EJ, McNamara CR, Harrelson JM, Pickett JP, Drezner MK. J Clin Endocrinol Metab; 1985 Apr 26; 60(4):711-7. PubMed ID: 4038714 [Abstract] [Full Text] [Related]
18. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets. Reusz GS, Latta K, Hoyer PF, Byrd DJ, Ehrich JH, Brodehl J. Lancet; 1990 May 26; 335(8700):1240-3. PubMed ID: 1971321 [Abstract] [Full Text] [Related]
19. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Marie PJ, Travers R, Glorieux FH. Calcif Tissue Int; 1982 Mar 26; 34(2):158-64. PubMed ID: 6282410 [Abstract] [Full Text] [Related]
20. X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. Costa T, Marie PJ, Scriver CR, Cole DE, Reade TM, Nogrady B, Glorieux FH, Delvin EE. J Clin Endocrinol Metab; 1981 Mar 26; 52(3):463-72. PubMed ID: 6893992 [Abstract] [Full Text] [Related] Page: [Next] [New Search]